Charles Schwab’s OnKure Therapeutics OKUR Stock Holding History
Bought
Maintained
Sold
Other funds holding OKUR
ACA
Charles Schwab's OKUR Position: Q3 2026 in Review
Charles Schwab held its OnKure Therapeutics (OKUR) position steady in Q3 2026 at 63,640 shares worth $173K. The position accounts for ﹤0.01% of the portfolio, ranked #3383.
Charles Schwab first reported a position in OKUR in Q2 2021 and has held it in 10 quarters since. The position peaked at $290K in Q2 2026. 83 funds tracked by Wall St. Rank hold OKUR as of Q3 2026.
- Charles Schwab held 63,640 shares of OnKure Therapeutics worth $173K as of Q3 2026.
- Charles Schwab left its OnKure Therapeutics share count unchanged in Q3 2026.
- OnKure Therapeutics made up ﹤0.01% of Charles Schwab's portfolio in Q3 2026, its #3383 holding.
- Charles Schwab first reported a position in OnKure Therapeutics in Q2 2021 and has held it in 10 quarters since.
- Charles Schwab's OnKure Therapeutics position peaked at $290K in Q2 2026.
- 83 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q3 2026.
Based on Charles Schwab's 13F filing for Q3 2026, filed 16 Nov 2026.